Apple Inc. Stock Outperforms Competitors On Strong Trading Day

Zynerba Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

ZYNE Zynerba Pharmaceuticals Inc

PDO PIMCO Dynamic Income Opportunities Fund

BOCT Innovator U.S. Equity Buffer ETF™ October

BAC Bank of America Corp

YARIY Yara International ASA

XOM Exxon Mobil Corp

XLF Financial Select Sector SPDR® Fund

XFLT XAI Octagon Floating Rate & Alternative Income Term Trust

WPC WP Carey Inc

WMT WALMART STORES INC

Health Care : Pharmaceuticals | Small Cap Value

Company profile

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).

Apple Inc. Stock Outperforms Competitors On Strong Trading Day

4:33 pm ET September 14, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Apple Inc. (AAPL) inched 0.88% higher to $175.74 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.81% to 13,926.05 and the Dow Jones Industrial Average rising 0.96% to 34,907.11.

The stock's rise snapped a two-day losing streak.

Apple Inc. closed $22.49 short of its 52-week high ($198.23), which the company achieved on July 19th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Microsoft Corp. (MSFT) rose 0.79% to $338.70, Alphabet Inc. Cl C (GOOGL) rose 1.08% to $138.99, and Alphabet Inc. Cl A (GOOGL) rose 1.02% to $138.10.

Trading volume (59.6 M) eclipsed its 50-day average volume of 57.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

September 14, 2023 16:33 ET (20:33 GMT)